NCT03147859View on ClinicalTrials.gov

Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection

PHASE2UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
HIV-infection/AIDS
Interventions
BIOLOGICAL

Vedolizumab (brand name Entyvio)

IV infusion

Trial Locations (1)

K1H 8L6

RECRUITING

The Ottawa Hospital -General Campus, Ottawa

Sponsors

Collaborators (1)

Cheo Research Institute
All Listed Sponsors
collaborator

Cheo Research Institute

OTHER

collaborator

Nebraska Centre for Substance Abuse Research

UNKNOWN

lead

Ottawa Hospital Research Institute

OTHER